Cord Blood Stem Cells Market Will Hit US$15 Billion By 2015

stem cell stocks

According to the report “Cord Blood Stem Cells: A Global Market Overview” available at umbilical cord and placenta, once considered medical waste have emerged to be a valuable source of stem cells. The cord blood stem cells show the potential to treat fatal diseases such as leukemia, cardiac attacks and debilitating diseases including Alzheimer’s and Parkinson’s. Cord blood stem cells are also widely used in therapies such as blood disorders, bone and tissue engineering, dermatology.

Global cord blood stem cells market for 2010 is estimated at about US$4.5 billion. The market is further projected to register a robust CAGR of 27.3% during the period 2006-2015 to reach US$15 billion by 2015. The report provides a listing of the companies engaged in collection, processing and banking of cord blood stem cells. This list also includes the companies engaged in the treatment of deadly diseases using CB stem cells.

Related Posts with Thumbnails

Leave a Reply

Contact Us

Tips, Leads, Suggestions, Just Want to Say Hello? Email Dan or Sarah at support (at) stemcellumbilicalcordblood (dot) com